Biochemical and structural characterization of CYP109A2, a vitamin D 3 25-hydroxylase from Bacillus megaterium

• Published in: The FEBS journal Vol. 284; no. 22; p. 3881
• Main Authors: Abdulmughni, Ammar, Jóźwik, Ilona K, Brill, Elisa, Hannemann, Frank, Thunnissen, Andy-Mark W H, Bernhardt, Rita
• Format: Journal Article
• Language: English
• Published: England 01-11-2017
• Subjects: Amino Acid Sequence; Bacillus megaterium - enzymology; Binding Sites; Biocatalysis; Catalytic Domain; Cholestanetriol 26-Monooxygenase - chemistry; Cholestanetriol 26-Monooxygenase - metabolism; Crystallography, X-Ray; Hydroxylation; Kinetics; Oxidation-Reduction; Phylogeny; Protein Conformation; Sequence Homology; Substrate Specificity; regio-selectivity; cytochrome P450; Bacillus megaterium; biocatalysis; vitamin D3
• ISSN: 1742-4658
• DOI: 10.1111/febs.14276

Cytochrome P450 enzymes are increasingly investigated due to their potential application as biocatalysts with high regio- and/or stereo-selectivity and under mild conditions. Vitamin D
(VD
) metabolites are of pharmaceutical importance and are applied for the treatment of VD
deficiency and other disorders. However, the chemical synthesis of VD
derivatives shows low specificity and low yields. In this study, cytochrome P450 CYP109A2 from Bacillus megaterium DSM319 was expressed, purified, and shown to oxidize VD
with high regio-selectivity. The in vitro conversion, using cytochrome P450 reductase (BmCPR) and ferredoxin (Fdx2) from the same strain, showed typical Michaelis-Menten reaction kinetics. A whole-cell system in B. megaterium overexpressing CYP109A2 reached 76 ± 5% conversion after 24 h and allowed to identify the main product by NMR analysis as 25-hydroxylated VD
. Product yield amounted to 54.9 mg·L
·day
, rendering the established whole-cell system as a highly promising biocatalytic route for the production of this valuable metabolite. The crystal structure of substrate-free CYP109A2 was determined at 2.7 Å resolution, displaying an open conformation. Structural analysis predicts that CYP109A2 uses a highly similar set of residues for VD
binding as the related VD
hydroxylases CYP109E1 from B. megaterium and CYP107BR1 (Vdh) from Pseudonocardia autotrophica. However, the folds and sequences of the BC loops in these three P450s are highly divergent, leading to differences in the shape and apolar/polar surface distribution of their active site pockets, which may account for the observed differences in substrate specificity and the regio-selectivity of VD
hydroxylation.
The atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 5OFQ (substrate-free CYP109A2).
Cytochrome P450 monooxygenase CYP109A2, EC 1.14.14.1, UniProt ID: D5DF88, Ferredoxin, UniProt ID: D5DFQ0, cytochrome P450 reductase, EC 1.8.1.2, UniProt ID: D5DGX1.